The National Cancer Institute approved the following clinical research studies last month.
As Ben Ho Park sees it, the mission of a cancer researcher doesn’t stop at the water’s edge. It follows that Park’s new role as director of Vanderbilt-Ingram Cancer Center is inseparable from his role as an executive of the Global Cancer Institute, a nonprofit that works with healthcare providers in low- and middle-income countries to improve survival rates for underserved cancer patients.
Up to 15% of U.S. counties—home to about 25 million Americans—fall outside the reach of the catchment area of this country’s cancer centers.
Richard O. Hynes, Erkki Ruoslahti, and Timothy A. Springer received the 2022 Albert Lasker Basic Medical Research Award for discoveries concerning integrins, key mediators of cell-matrix and cell-cell adhesion in physiology and disease.
Siteman Cancer Center and University of Missouri Health Care’s Ellis Fischel Cancer Center have formed a collaboration to improve cancer care throughout Missouri.
Gov. Gavin Newsom has signed the California Cancer Care Equity Act (SB 987), a bill that will expand access to specialized cancer care for Medi-Cal patients who receive a complex cancer diagnosis.
Ted Schwartz, a cancer survivor, gifted $15M to City of Hope that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the CAR T-cell therapy that saved his life.
Jasmin A. Tiro has been named associate director of Cancer Prevention and Population Sciences at University of Chicago Medicine Comprehensive Cancer Center.
NCI has renewed UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center Kidney Cancer Program Specialized Program of Research Excellence award.
The Parker Institute for Cancer Immunotherapy, a network of the largest concentration of immuno-oncology expertise in the world, has added Dana-Farber Cancer Institute and Gladstone Institutes to its network of academic and medical research institutions.
